Enhanced Expression of FCER1G Predicts Positive Prognosis in Multiple Myeloma

Journal of Cancer- Australia

doi 10.7150/jca.37313

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

Ivyspring International Publisher

Related search

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Rituximab in CD20 Positive Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Prognosis Value of RBBP8 Expression in Plasma Cell Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Expression of Polycomb Targets Predicts Breast Cancer Prognosis

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2013English

Prognostic Value of CD56 Expression in Multiple Myeloma

Research in Oncology
2020English

High Hepsin Expression Predicts Poor Prognosis in Gastric Cancer

Scientific Reports
Multidisciplinary
2016English

CSF Β-Amyloid Predicts Prognosis in Patients With Multiple Sclerosis

Multiple Sclerosis
Neurology
2018English

Co-Expression Network Analysis Identified FCER1G in Association With Progression and Prognosis in Human Clear Cell Renal Cell Carcinoma

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2017English

Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy